Medtronic PLC
NYSE:MDT

Watchlist Manager
Medtronic PLC Logo
Medtronic PLC
NYSE:MDT
Watchlist
Price: 81.54 USD 0.17%
Market Cap: 104.6B USD
Have any thoughts about
Medtronic PLC?
Write Note

Medtronic PLC
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Medtronic PLC
Other Long-Term Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
Medtronic PLC
NYSE:MDT
Other Long-Term Assets
$6.3B
CAGR 3-Years
9%
CAGR 5-Years
20%
CAGR 10-Years
17%
Trinity Biotech PLC
NASDAQ:TRIB
Other Long-Term Assets
$927k
CAGR 3-Years
-38%
CAGR 5-Years
-35%
CAGR 10-Years
-22%
STERIS plc
NYSE:STE
Other Long-Term Assets
$60.3m
CAGR 3-Years
6%
CAGR 5-Years
-5%
CAGR 10-Years
20%
No Stocks Found

Medtronic PLC
Glance View

Market Cap
104.6B USD
Industry
Health Care
Economic Moat
Narrow

In the intricate world of medical technology, Medtronic PLC stands tall as one of the foremost innovators transforming the landscape of healthcare. Founded in 1949 as a humble medical supply repair shop in Minnesota, Medtronic has grown into a global titan, driven by the enduring mission to alleviate pain, restore health, and extend life. The company's breadth is vast, touching nearly every aspect of patient care, from advanced robotic-assisted surgery systems to sophisticated insulin pumps. At its core, Medtronic thrives on relentless research and development, continually bridging the gap between cutting-edge technology and practical medical solutions. By forging deep alliances with healthcare providers and systems around the globe, the company ensures its innovations are not only groundbreaking but also widely accessible. The company's financial engine purrs to life primarily through the development and sale of medical devices across four major segments: Cardiac and Vascular Group, Minimally Invasive Therapies, Restorative Therapies Group, and Diabetes Group. Each unit meticulously focuses on innovating and providing solutions relevant to its field, ensuring a diversified portfolio with robust pipelines. For instance, within the Cardiac and Vascular Group, Medtronic supplies life-saving products like pacemakers and stents while also exploring breakthrough therapies such as transcatheter heart valves. By capitalizing on a global presence, the company strategically taps into both mature markets in North America and Europe and emerging markets across Asia and Latin America, thereby driving substantial revenue streams. Through this multifaceted operational framework, Medtronic not only sustains its market dominance but also reinvests in the future of medical technology, symbolizing a perpetual cycle of growth and innovation.

MDT Intrinsic Value
99.45 USD
Undervaluation 18%
Intrinsic Value
Price

See Also

What is Medtronic PLC's Other Long-Term Assets?
Other Long-Term Assets
6.3B USD

Based on the financial report for Oct 25, 2024, Medtronic PLC's Other Long-Term Assets amounts to 6.3B USD.

What is Medtronic PLC's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 10Y
17%

Over the last year, the Other Long-Term Assets growth was 8%. The average annual Other Long-Term Assets growth rates for Medtronic PLC have been 9% over the past three years , 20% over the past five years , and 17% over the past ten years .

Back to Top